Opioid Use Disorder
📧 Sign up to get email alerts when something new happens for Opioid Use Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-06-02FDA Approved: METHADOSE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for METHADOSE (methadone hydrochloride) submitted by SpecGx LLC.
-
FDA approval · 2014-05-15FDA Approved: BUPRENORPHINE AND NALOXONE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for the buprenorphine and naloxone combination from Actavis Pharma, Inc.
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: Induction of Opioid-Dependent Individuals Onto Buprenorphine and Buprenorphine/Naloxone [Phase 2]
Phase 2 trial update evaluating induction of opioid-dependent individuals onto buprenorphine or buprenorphine/naloxone, with results posted.
-
CLINICAL_TRIALS trial_result · 2014-05-06Clinical Trial Update: Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications [Phase 1]
A Phase 1 trial evaluated potential interactions between buprenorphine and HIV and tuberculosis medications; the study has completed.
-
FDA approval · 2014-04-28FDA Approved: SUBOXONE — Supplemental Application (INDIVIOR INC.)
The FDA approved a supplemental application for Suboxone (buprenorphine/naloxone) from Indivior Inc., updating the regulatory status for the…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-04-18FDA Approved: BUPRENORPHINE HCL AND NALOXONE HCL — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application from Amneal Pharmaceuticals LLC for a generic Buprenorphine HCl and Naloxone HCl product. It is indi…
-
FDA approval · 2014-04-17FDA Approved: VIVITROL — Supplemental Application (Alkermes, Inc.)
The FDA approved a supplemental application for VIVITROL (naltrexone) submitted by Alkermes, Inc.
-
FDA approval · 2014-04-16FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (VistaPharm, LLC)
The FDA approved a supplemental application for methadone hydrochloride submitted by VistaPharm, LLC.
-
FDA approval · 2014-04-16FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for methadone hydrochloride from Hikma Pharmaceuticals USA Inc., approving a generic version of this…
-
FDA approval · 2014-04-16FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for methadone hydrochloride submitted by Hikma Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS research · 2014-04-16Clinical Trial Update: Deep Brain Stimulation of Nucleus Accumbens to Prevent Opiate Relapse [NA]
This entry describes a clinical trial evaluating deep brain stimulation of the nucleus accumbens to prevent relapse in opioid use disorder; …
-
CLINICAL_TRIALS trial_result · 2014-04-03Clinical Trial Update: Methadone Maintenance for Prisoners [Phase 3]
A Phase 3 trial evaluating methadone maintenance for prisoners with heroin addiction has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: Clinical Efficacy and Serum Proteomic Profiling of Suan-Zao-Ren Tang for Sleep Disturbance During Methadone Maintenance [Phase 2]
Phase 2 clinical trial evaluating the efficacy of Suan-Zao-Ren Tang for sleep disturbance in patients on methadone maintenance for opioid us…
-
FDA approval · 2014-03-12FDA Approved: SUBOXONE — Supplemental Application (INDIVIOR INC.)
FDA approved a supplemental application for SUBOXONE (buprenorphine hydrochloride, naloxone hydrochloride) submitted by Indivior Inc.
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: Testing a Community-Friendly Risk Reduction Intervention for Injection Drug Users [NA]
This ClinicalTrials.gov entry reports the completion of a community-friendly risk reduction intervention trial for injection drug users; the…
-
CLINICAL_TRIALS trial_result · 2014-02-21Clinical Trial Update: Incentive-based Smoking Cessation for Methadone Patients [Phase 2]
A Phase 2 clinical trial evaluating incentive-based smoking cessation among patients currently receiving methadone or buprenorphine for opio…
-
CLINICAL_TRIALS trial_result · 2014-02-14Clinical Trial Update: Observational Study to Assess the Efficacy and Tolerability of Eptadone®, in Heroin Addicted Patients in a MMT
The document indicates the completion of an observational study evaluating the efficacy and tolerability of Eptadone in heroin-addicted pati…
-
FDA approval · 2014-01-14FDA Approved: ZUBSOLV — Supplemental Application (Orexo US, Inc.)
FDA approved a supplemental application for ZUBSOLV (buprenorphine hydrochloride and naloxone hydrochloride) from Orexo US, Inc.
-
CLINICAL_TRIALS trial_result · 2013-12-11Clinical Trial Update: Insomnia and Drug Relapse Risk [Phase 3]
Phase 3 trial results update assessing the link between insomnia and relapse risk in patients with opioid use disorder. Results have been po…
-
CLINICAL_TRIALS trial_result · 2013-12-11Clinical Trial Update: Naltrexone Implants as Relapse Prevention [Phase 2, Phase 3]
Clinical trial update reports termination of a Phase 2/Phase 3 study evaluating Naltrexone implants for relapse prevention in opioid use dis…
-
FDA approval · 2013-11-22FDA Approved: SUBOXONE — Supplemental Application (INDIVIOR INC.)
FDA approved a supplemental application for Suboxone (buprenorphine/naloxone) by Indivior Inc.
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: Effectiveness of Lofexidine to Prevent Stress-Related Opiate Relapse During Naltrexone Treatment - 1 [Phase 2]
Phase 2 trial results evaluating whether lofexidine can reduce stress-related opiate relapse in people treated with naltrexone; results were…
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Using mHealth to Aid Opioid Addicts
A completed clinical trial evaluated mobile health tools to aid individuals with opioid use disorder in preventing relapse.
-
FDA approval · 2013-09-19FDA Approved: DISKETS — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for DISKETS (methadone hydrochloride) from Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2013-09-04FDA Approved: BUPRENORPHINE HCL AND NALOXONE HCL — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for Buprenorphine HCl and Naloxone HCl from Amneal Pharmaceuticals LLC. This represents an additiona…